252 related articles for article (PubMed ID: 18361452)
1. Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients.
Levy H; Kalish LA; Cannon CL; García KC; Gerard C; Goldmann D; Pier GB; Weiss ST; Colin AA
Pediatr Pulmonol; 2008 May; 43(5):463-71. PubMed ID: 18361452
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
Li Z; Kosorok MR; Farrell PM; Laxova A; West SE; Green CG; Collins J; Rock MJ; Splaingard ML
JAMA; 2005 Feb; 293(5):581-8. PubMed ID: 15687313
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.
Parad RB; Gerard CJ; Zurakowski D; Nichols DP; Pier GB
Infect Immun; 1999 Sep; 67(9):4744-50. PubMed ID: 10456926
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with mucoid transition of Pseudomonas aeruginosa in cystic fibrosis patients.
Martha B; Croisier D; Fanton A; Astruc K; Piroth L; Huet F; Chavanet P
Clin Microbiol Infect; 2010 Jun; 16(6):617-23. PubMed ID: 20002106
[TBL] [Abstract][Full Text] [Related]
5. Clearance of initial mucoid Pseudomonas aeruginosa in patients with cystic fibrosis.
Troxler RB; Hoover WC; Britton LJ; Gerwin AM; Rowe SM
Pediatr Pulmonol; 2012 Nov; 47(11):1113-22. PubMed ID: 22496040
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor.
Heltshe SL; Mayer-Hamblett N; Burns JL; Khan U; Baines A; Ramsey BW; Rowe SM;
Clin Infect Dis; 2015 Mar; 60(5):703-12. PubMed ID: 25425629
[TBL] [
